Skip to main content
  • Consumer Website
  • Contact Us
 
 
Bayer logo
Bayer logo
Logo
Logo
 
 

ATTENTION

The information on this page is intended for healthcare professionals in the.
United States and is not intended for the general public.

I AM A HEALTHCARE PROFESSIONAL

I AM NOT A HEALTHCARE PROFESSIONAL

Home
  • Product
  • Efficacy
  • Pediatric
  • PRN Dosing
  • Safety & Tolerability
  • FAQ
  • Resources
  • Sign Up for Coupons and More
Bayer Cross Logo
  1. Home
  2. Efficacy
Image
Image

Astepro® starts working in 30 minutes, while INS sprays can take up to 12 hours to provide relief on day 1. INS sprays can take 3 to 14 days to reach maximum efficacy levels.1-8

ASTEPRO SIGNIFICANTLY IMPROVED ALL 4 TNSS COMPONENTS2,9-11

Image

Results of a 2-week, placebo-controlled, double-blind study comparing azelastine HCI 0.15% nasal spray, 2 sprays per nostril once daily, with placebo in patients with SAR (n=266 for patients receiving Astepro and n=266 for patients receiving placebo). The study was conducted in the United States during Texas Mountain Cedar season. The primary efficacy variable was change from baseline in 12-hour reflective TNSS over the entire 2 weeks of treatment. TNSS consisted of nasal congestion, itchy nose, runny nose, and sneezing, scored on a 4-point (0 to 3) scale with a maximum possible daily score of 24. 

MECHANISM OF ACTION:
ASTEPRO® WORKS DIRECTLY AT THE SITE OF NASAL ALLERGIES12

PRESCRIPTION HERITAGE – SAME FULL STRENGTH AS ASTEPRO® RX 0.15% 

Astepro® Allergy is the same strength as prescription Astepro® (azelastine HCI) 0.15% Nasal Spray, 205.5 mcg (Rx approval in 2009), and is the maximum strength of azelastine HCI available as a prescription or over the counter.13-15 

It is different than both Astelin® (azelastine HCI) Nasal Spray 137 mcg (Rx approval in 1996), and Astepro® (azelastine HCI) 0.10% Nasal Spray 137 mcg (Rx approval in 2008).14-16

GET SUPPORT MATERIALS AND READ CLINICAL STUDIES 

GET SUPPORT MATERIALS AND READ CLINICAL STUDIES  

VISIT RESOURCES

INS, intranasal steroid; SAR, seasonal allergic rhinitis; TNSS, Total Nasal Symptom Score. 
*Compared with other steroid allergy sprays, on day 1.

REFERENCES:
1. Data on file. Bayer. Study 20877. Onset of action. 2. Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(6):628-633. doi:10.2500/aap.2009.30.3296 3. Flonase® website. Accessed March 2, 2022. https://www.flonase.com/faqs/ 4. Flonase®. Prescribing Information. GlaxoSmithKline; 2019. 5. GSK health partner website. Accessed March 2, 2022. https://www.gskhealthpartner.com/en-us/respiratory-health/brands/flonase-products/flonase/dosing-administration-flonase-allergy-relief/ 6. Nasacort® website. Accessed March 2, 2022. https://www.nasacort.com/allergy-nasal-spray-nasacort-faqs/ 7. Nasacort® AQ. Prescribing information. Sanofi-aventis U.S. LLC; 2008. 8. Rhinocort website. Accessed November 11, 2021. https://www.rhinocort.com/allergy-nasal-spray/adult-otc-spray 9. Data on file. Bayer. MP440 CSR. Symptom scores. 10. van Bavel J, Howland WC, Amar NJ, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(5):512-518. doi:10.2500/aap.2009.30.3284 11. Howland WC, Amar NJ, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen. Int Forum Allergy Rhinol. 2011;1(4):275-279. doi:10.1002/alr.20065  12. Horak F. Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis. Ther Clin Risk Management. 2008;4(5):1009-1022. 13. NDA 213872. 14. Astepro®. Prescribing information. Meda Pharmaceuticals Inc; 2018. 15. US Department of Health and Human Services. Pediatric Postmarketing Pharmacovigilance and Drug Utilization Review. November 3, 2016. Accessed October 28, 2021. https://www.fda.gov/media/100100/download 16. Astelin. Prescribing information. Meda Pharmaceuticals Inc; 2014. 

SIGN UP TO RECEIVE UPDATES ABOUT ASTEPRO® ALLERGY

 
Get product updates, coupons and free patient samples when they become available.

Astepro Logo
  • PRODUCT
  • EFFICACY
  • PEDIATRIC
  • PRN DOSING
  • SAFETY & TOLERABILITY
  • FAQ
  • RESOURCES
  • SIGN UP FOR COUPONS AND MORE
  • SITE MAP

©2023. Bayer and the Bayer Cross are registered trademarks of Bayer. Astepro is a Viatris Company trademark. Used under license. All third party trademarks used herein are registered trademarks of their respective owners.

USE AS DIRECTED

  • Bayer Global
  • Bayer US
  • Bayer Consumer Health
  • Conditions of Use
  • Privacy Statement
  • Imprint
  • California Transparency in Supply Chains
  • Satisfaction Guarantee
  • AdChoices
  • Do not sell or share my Personal Data
  • Accessibility

Level Access website accessibility icon